-
Article
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation
-
Article
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort
The BCL2 inhibitor venetoclax is transforming the management of patients with chronic lymphocytic leukemia (CLL), given its high efficacy in relapsed/refractory CLL as observed in both early-phase and randomiz...
-
Article
Open AccessRetraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Article
RETRACTED ARTICLE: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML
Chaperone-mediated autophagy (CMA) is a highly selective form of autophagy. During CMA, the HSC70 chaperone carries target proteins endowed with a KFERQ-like motif to the lysosomal receptor LAMP2A, which then ...
-
Article
Open AccessIL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential
CSF-1 and IL-34 share the CSF-1 receptor and no differences have been reported in the signaling pathways triggered by both ligands in human monocytes. IL-34 promotes the differentiation and survival of monocyt...
